Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,378,206
in 4 filings, $15.4M under 10b5-1 plans

Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-01 Sachdev Amit EVP, Chief Patient Officer Grant or award +7,866 79,752
2023-02-01 LEIDEN JEFFREY M Executive Chairman Grant or award +31,462 33,885
2023-02-01 LEIDEN JEFFREY M Executive Chairman Grant or award +34,890 68,775
2023-02-01 LEIDEN JEFFREY M Executive Chairman Grant or award +10,226 79,001
2023-02-01 Kewalramani Reshma CEO & President Grant or award +12,388 101,986
2023-02-01 Kewalramani Reshma CEO & President Grant or award +29,118 131,104
2023-02-01 Kewalramani Reshma CEO & President Grant or award +26,972 158,076
2023-02-01 Bozic Carmen EVP and CMO Grant or award +10,324 59,836
2023-02-01 Bozic Carmen EVP and CMO Grant or award +10,262 70,098
2023-02-01 Bozic Carmen EVP and CMO Grant or award +7,866 77,964
2023-02-01 Biller Jonathan EVP and Chief Legal Officer Grant or award +6,293 11,587
2023-02-01 Arbuckle Stuart A EVP, COO Grant or award +12,388 70,419
2023-02-01 Arbuckle Stuart A EVP, COO Grant or award +14,624 85,043
2023-02-01 Arbuckle Stuart A EVP, COO Grant or award +11,209 96,252
2023-02-01 Ambrose Kristen SVP & Chief Accounting Officer Grant or award +2,566 6,062
2023-02-01 Ambrose Kristen SVP & Chief Accounting Officer Grant or award +2,950 9,012
2023-02-01 ALTSHULER DAVID EVP, Global Research and CSO Grant or award +12,388 48,465
2023-02-01 ALTSHULER DAVID EVP, Global Research and CSO Grant or award +12,314 60,779
2023-02-01 ALTSHULER DAVID EVP, Global Research and CSO Grant or award +7,866 68,645
2023-01-31 Sanna Bastiano EVP, Cell & Genetic Therapies Sale −106 $325.00 $34K 37,998

Page 39 of 40 · 781 trades